The partnership will offer online access to Almac’s integrated services, from development to the commercial-scale production of active pharmaceutical ingredients, to clients worldwide.
Almac Sciences has profiled its service offerings on the Science Exchange website, including the recently announced full suite of analytical services now offered from its European and North American facilities. Employing 150 highly skilled analysts working in GMP / GLP environments, Almac has experience in the analysis of both small and large molecules and a range of product types, including peptides, biologics, conjugates, potents and controlled substances.
Science Exchange was founded in 2011 with the mission of democratising access to the world’s scientific expertise in order to move the research world forward at a faster pace. Science Exchange’s secure online solution to manage R&D services makes it easy for researchers to access the world’s leading scientific service providers and innovative technologies.
“Science Exchange gives Almac Sciences another avenue where potential clients can find us in a quick and efficient manner,” said Denis Geffroy, VP Business Development, Almac Sciences. “This unique platform will enable us to provide added value across the clinical development lifecycle and help drive our clients to R&D success.”
Elizabeth Iorns, PhD, CEO and co-founder of Science Exchange, commented: “We are delighted that Almac has chosen to profile its offerings on our marketplace, where researchers from across the globe can readily access details on Almac’s vast range of services. Clients can use our platform to order services directly from Almac under a single, pre-established contract, enabling them to save time and money.”
